Inhibition of peritoneal metastasis in an animal gastric cancer model by interferon-gamma and interleukin-2.
The anti-tumor activity of interferon-gamma (IFN-gamma) and interleukin-2 (IL-2) have been shown in human gastric cancer cell lines, however, their therapeutic effects on peritoneal metastasis have not been investigated. The anti-tumor activity of IFN-gamma and IL-2 against the gastric cancer cell line, MKN45, was evaluated by in vitro antiproliferation assays and in animal-tumor models of intraperitoneal (i.p.) and subcutaneous (s.c.) tumors. Survival of the animals with i.p. tumor was longest in those given IFN-gamma, followed by those given IL-2, IL-2 + IFN-gamma and saline (control) with median survival of 88 +/- 27 days, 73 +/- 30 days, 53 +/- 20 days and 32 +/- 1.1 days, respectively (p < 0.001 vs control). In animals with s.c. tumor, IFN-gamma significantly inhibited tumor growth as compared with the control. In vitro, IFN-gamma alone inhibited the growth of MKN45 and induced apoptosis, while IL-2 had no additional effect. IFN-gamma inhibited the growth of gastric cancer cells in vitro and in a peritoneal tumor model. The therapeutic effects were partially antagonized by IL-2.